Biosimilars: Patient Understanding and Attitudes
Biosimilars are here; what will patients do?
Biologic therapies have delivered significant improvement in outcomes for many autoimmune patients. The advent of biosimilar products will change the current therapeutic landscape and force many patients to make new decisions about their treatment, driving the need for awareness and education initiatives. This study presents information about both biologics and biosimilars to patients and gauges their ability to understand the differences, as well as exploring switching and substitution behaviors.
After you complete and submit the form below, we will contact you to arrange payment. Please note the reports you would like to order in the message box. All products are delivered electronically and can be printed upon receipt.